Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jul 15, 2022; 14(7): 1295-1306
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1295
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1295
Figure 2 5-hydroxymethylcytosine level measurement compared between tumor vs control tissues and Helicobacter pylori-negative vs positive subgroups.
A: Tumor vs control tissues; B: Helicobacter pylori -negative vs positive subgroups. 5-hmC: 5-hydroxymethylcytosine.
- Citation: Fu YL, Wu YH, Cao DH, Jia ZF, Shen A, Jiang J, Cao XY. Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients. World J Gastrointest Oncol 2022; 14(7): 1295-1306
- URL: https://www.wjgnet.com/1948-5204/full/v14/i7/1295.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i7.1295